ArticlePloS one2020

Serum discrimination and phenotype assessment of coronary artery disease patents with and without type 2 diabetes prior to coronary artery bypass graft surgery.

James R Hocker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.